Central Trust Company’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
TWM
EFG
APA
FGA
PFA
Central Trust Company's BTAL Position: Q2 2023 in Review
Central Trust Company sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 804 shares — an estimated $16.4K sold.
Central Trust Company first reported a position in BTAL in Q1 2023 and held it in 1 quarter. The position peaked at $16.4K in Q1 2023. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.
- Central Trust Company reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
- Central Trust Company sold 804 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $16.4K.
- Central Trust Company first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 1 quarter.
- Central Trust Company's AGF US Market Neutral Anti-Beta Fund position peaked at $16.4K in Q1 2023.
- 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.
Based on Central Trust Company's 13F filing for Q2 2023, filed 26 Jul 2023.